Evaluation of the effectiveness of Persian Medicine product (Padzahr) in controlling the symptoms of patients with COVID-19: A pilot study

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

JOKAR ASSIE; DAVOUDI ALI REZA; HASHEM DABAGHIAN FATANEH; KORDAFSHARI GHOLAMREZA; MOHAMMADI KENARI HOORIEH

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Journal of Islamic and Iranian Traditional Medicine Year:2022 | Volume:13 | Issue:2 Page(s): 105-112

Download Full-Text

Persian Verion

View:

Download:

Cites:

Information Journal Paper

Title

Evaluation of the effectiveness of Persian Medicine product (Padzahr) in controlling the symptoms of patients with COVID-19: A pilot study

Author(s)

Keywords

Persian Medicine

COVID-19

Acute Respiratory Syndrome

Abstract

Background and Purpose: Coronaviruses, with single-stranded RNA, are widespread and cause respiratory, gastrointestinal, liver, and neurological diseases. This study aimed to evaluate the effect of Padzahr capsules to control clinical symptoms in patients with COVID-19 in a pilot clinical study. Materials and Methods: This is a randomized controlled clinical trial study that was conducted in the summer and autumn of 1400 AD (2021) in Mazandaran province. The statistical population comprised COVID-19 patients based on the Iranian protocol and based on the set criteria. In this study, 68 definitive patients were randomly divided into intervention (Padzahr) and control groups. All patients admitted with COVID-19 in the infectious ward received routine corona treatment drugs, and the intervention group were additionally administered six Padzahr capsules per day (manufactured by NIAK with license number 0385-94). Data were analyzed by SPSS software (version: 17) using the ITT method. The criterion for statistical significance was a value of P less than 0. 05. Results: At the time of admission, there was no significant difference between the two groups in terms of severity of signs and symptoms (p> 0. 05),The severity of signs and symptoms during hospitalization did not show a statistically significant difference. At 14-day follow-up, 28 patients in the drug group and 24 patients in the control group responded. Twenty-two patients (78. 6%) in the drug group and 11 patients (45. 8%) in the control group reported complete improvement of symptoms. No side effects were observed or reported in Padzahr users. Conclusion: Padzahr caused a decrease in the severity of signs and symptoms of COVID-19 disease, but did not show a statistically significant difference compared to the control group during hospitalization. At follow-up two weeks later, the intervention group had better conditions and fewer symptoms.

Cites

No record.

References

Cite

APA: Copy

JOKAR, ASSIE, DAVOUDI, ALI REZA, HASHEM DABAGHIAN, FATANEH, KORDAFSHARI, GHOLAMREZA, & MOHAMMADI KENARI, HOORIEH. (2022). Evaluation of the effectiveness of Persian Medicine product (Padzahr) in controlling the symptoms of patients with COVID-19: A pilot study. JOURNAL OF ISLAMIC AND IRANIAN TRADITIONAL MEDICINE, 13(2 ), 105-112. SID. https://sid.ir/paper/1115476/en

Vancouver: Copy

JOKAR ASSIE, DAVOUDI ALI REZA, HASHEM DABAGHIAN FATANEH, KORDAFSHARI GHOLAMREZA, MOHAMMADI KENARI HOORIEH. Evaluation of the effectiveness of Persian Medicine product (Padzahr) in controlling the symptoms of patients with COVID-19: A pilot study. JOURNAL OF ISLAMIC AND IRANIAN TRADITIONAL MEDICINE[Internet]. 2022;13(2 ):105-112. Available from: https://sid.ir/paper/1115476/en

IEEE: Copy

ASSIE JOKAR, ALI REZA DAVOUDI, FATANEH HASHEM DABAGHIAN, GHOLAMREZA KORDAFSHARI, and HOORIEH MOHAMMADI KENARI, “Evaluation of the effectiveness of Persian Medicine product (Padzahr) in controlling the symptoms of patients with COVID-19: A pilot study,” JOURNAL OF ISLAMIC AND IRANIAN TRADITIONAL MEDICINE, vol. 13, no. 2 , pp. 105–112, 2022, [Online]. Available: https://sid.ir/paper/1115476/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops